Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-02-12 19:44:23 ET
Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call February 12, 2026 5:00 PM EST...
Read the full article on Seeking Alpha
For further details see:
Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript
VistaGen Therapeutics Inc.
NASDAQ: VTGN
VTGN Trading
3.37% G/L:
$0.6375 Last:
332,147 Volume:
$0.60 Open:
VTGN Latest News
March 04, 2026 09:00:00 am
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 16, 2026 to Discuss Your Rights - VTGN
February 25, 2026 09:00:00 am
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen Lawsuit - VTGN
February 25, 2026 08:30:00 am
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
VTGN Stock Data
$23,061,394
27,595,472
0.51%
65
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
